Encuesta de Evaluación del Desempeño Docente 15 JanJanuary 15 at 00:012025-01-15 00:01:15

Nota Final 12 Dec 202412/12/24 at 18:422024-12-12 18:42:12

Mario Rivera M.

Revisión Corrección A2 12 Dec 202412/12/24 at 18:282024-12-12 18:28:12

Mario Rivera M.

Promedio Seminarios 12 Dec 202412/12/24 at 10:322024-12-12 10:32:12

José M. Osorio Sandoval

Coevaluación 12 Dec 202412/12/24 at 10:312024-12-12 10:31:12

José M. Osorio Sandoval

Coevaluaciones del Curso 11 Dec 202411/12/24 at 11:292024-12-11 11:29:11

José M. Osorio Sandoval

Control Presentaciones 2 10 Dec 202410/12/24 at 11:372024-12-10 11:37:10

Mario Rivera M.

Coevaluaciones del Curso 6 Dec 202406/12/24 at 15:562024-12-06 15:56:06

José M. Osorio Sandoval

Rubrica de coevaluación en seminario BF 2024.docx 6 Dec 202406/12/24 at 15:562024-12-06 15:56:06

José M. Osorio Sandoval

Rubrica de coevaluación en seminario BF 2024.docx 6 Dec 202406/12/24 at 15:562024-12-06 15:56:06

José M. Osorio Sandoval

Trabajo Investigación Fármaco Biologico 6 Dec 202406/12/24 at 15:212024-12-06 15:21:06

Mario Rivera M.

Revisión A2 6 Dec 202406/12/24 at 10:342024-12-06 10:34:06

José M. Osorio Sandoval

Información sobre controles recuperativos de seminarios 6 Dec 202406/12/24 at 10:162024-12-06 10:16:06

José M. Osorio Sandoval

Prueba A2 4 Dec 202404/12/24 at 15:092024-12-04 15:09:04

Mario Rivera M.

Control Presentaciones 1 3 Dec 202403/12/24 at 12:222024-12-03 12:22:03

Mario Rivera M.

Presentaciones Finales 22 Nov 202422/11/24 at 10:432024-11-22 10:43:22

Félix Lavín

Virus vivo varicela cepa Oka-1.pdf 20 Nov 202420/11/24 at 23:552024-11-20 23:55:20

Juan Barrios F.

Basiliximab - Secc 4 - Grupo 2.pdf 20 Nov 202420/11/24 at 23:342024-11-20 23:34:20

Marcelo Sepúlveda V.

G1-S2 TEDUGLUTIDA 20 Nov 202420/11/24 at 23:262024-11-20 23:26:20

Alberto Olivares G.

Trabajo Final Atezolizumab 20 Nov 202420/11/24 at 22:502024-11-20 22:50:20

Nicolás Ávila F.

G1 - S1 Agalsidasa Alfa Biotecnologia.pdf 20 Nov 202420/11/24 at 22:402024-11-20 22:40:20

Ricardo Lobos

L-asparaginasa S4 G3 20 Nov 202420/11/24 at 22:402024-11-20 22:40:20

Daniela Morales A.

Agalsidasa Alfa Biotecnologia.pdf 20 Nov 202420/11/24 at 22:402024-11-20 22:40:20

Ricardo Lobos

Semaglutida S2/G2.pdf 20 Nov 202420/11/24 at 22:392024-11-20 22:39:20

Vicente Mickle

Trabajo Final Risankizumab.pdf 20 Nov 202420/11/24 at 22:332024-11-20 22:33:20

Andrea Landeros